BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32795899)

  • 1. Human breast milk oligosaccharides attenuate necrotizing enterocolitis in rats by suppressing mast cell accumulation, DPPI activity and TLR4 expression in ileum tissue, and regulating mitochondrial damage of Caco-2 cells.
    He-Yang J; Zhang W; Liu J; Xue P; Zhou X
    Int Immunopharmacol; 2020 Nov; 88():106881. PubMed ID: 32795899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylated human milk oligosaccharides prevent intestinal inflammation by inhibiting toll like receptor 4/NLRP3 inflammasome pathway in necrotizing enterocolitis rats.
    Zhang W; He-Yang J; Tu W; Zhou X
    Nutr Metab (Lond); 2021 Jan; 18(1):5. PubMed ID: 33407596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causative role of mast cell and mast cell-regulatory function of disialyllacto-N-tetraose in necrotizing enterocolitis.
    Zhang W; He-Yang J; Zhuang W; Liu J; Zhou X
    Int Immunopharmacol; 2021 Jul; 96():107597. PubMed ID: 33812262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.
    Sodhi CP; Wipf P; Yamaguchi Y; Fulton WB; Kovler M; Niño DF; Zhou Q; Banfield E; Werts AD; Ladd MR; Buck RH; Goehring KC; Prindle T; Wang S; Jia H; Lu P; Hackam DJ
    Pediatr Res; 2021 Jan; 89(1):91-101. PubMed ID: 32221473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Milk Oligosaccharides Protect against Necrotizing Enterocolitis by Inhibiting Intestinal Damage via Increasing the Proliferation of Crypt Cells.
    Wang C; Zhang M; Guo H; Yan J; Liu F; Chen J; Li Y; Ren F
    Mol Nutr Food Res; 2019 Sep; 63(18):e1900262. PubMed ID: 31207104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Function Relationships of Human Milk Oligosaccharides on the Intestinal Epithelial Transcriptome in Caco-2 Cells and a Murine Model of Necrotizing Enterocolitis.
    Wu RY; Li B; Horne RG; Ahmed A; Lee D; Robinson SC; Zhu H; Cadete M; Alganabi M; Filler R; Johnson-Henry KC; Delgado-Olguin P; Pierro A; Sherman PM
    Mol Nutr Food Res; 2022 Feb; 66(4):e2100893. PubMed ID: 34921749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Role for Necroptosis in the Pathogenesis of Necrotizing Enterocolitis.
    Werts AD; Fulton WB; Ladd MR; Saad-Eldin A; Chen YX; Kovler ML; Jia H; Banfield EC; Buck RH; Goehring K; Prindle T; Wang S; Zhou Q; Lu P; Yamaguchi Y; Sodhi CP; Hackam DJ
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):403-423. PubMed ID: 31756560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model.
    Tian F; Liu GR; Li N; Yuan G
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4711-4719. PubMed ID: 29131241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Milk Oligosaccharides Increase Mucin Expression in Experimental Necrotizing Enterocolitis.
    Wu RY; Li B; Koike Y; Määttänen P; Miyake H; Cadete M; Johnson-Henry KC; Botts SR; Lee C; Abrahamsson TR; Landberg E; Pierro A; Sherman PM
    Mol Nutr Food Res; 2019 Feb; 63(3):e1800658. PubMed ID: 30407734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Milk Oligosaccharides Protect against Necrotizing Enterocolitis by Activating Intestinal Cell Differentiation.
    Li B; Wu RY; Horne RG; Ahmed A; Lee D; Robinson SC; Zhu H; Lee C; Cadete M; Johnson-Henry KC; Landberg E; Alganabi M; Abrahamsson T; Delgado-Olguin P; Pierro A; Sherman PM
    Mol Nutr Food Res; 2020 Nov; 64(21):e2000519. PubMed ID: 32926533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milk Fat Globule Membrane Ameliorates Necrotizing Enterocolitis in Neonatal Rats and Suppresses Lipopolysaccharide-Induced Inflammatory Response in IEC-6 Enterocytes.
    Zhang D; Wen J; Zhou J; Cai W; Qian L
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):863-873. PubMed ID: 30613991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.
    Weis VG; Deal AC; Mekkey G; Clouse C; Gaffley M; Whitaker E; Peeler CB; Weis JA; Schwartz MZ; Atala A
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G658-G674. PubMed ID: 33566727
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chen Z; Zhang Y; Lin R; Meng X; Zhao W; Shen W; Fan H
    J Med Microbiol; 2020 May; 69(5):748-758. PubMed ID: 32209170
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased development of necrotizing enterocolitis in IL-18-deficient mice.
    Halpern MD; Khailova L; Molla-Hosseini D; Arganbright K; Reynolds C; Yajima M; Hoshiba J; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G20-6. PubMed ID: 17947451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.
    Ling X; Linglong P; Weixia D; Hong W
    PLoS One; 2016; 11(8):e0161635. PubMed ID: 27551722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-κB signaling pathways.
    Yu R; Jiang S; Tao Y; Li P; Yin J; Zhou Q
    J Cell Physiol; 2019 Aug; 234(8):13431-13438. PubMed ID: 30618088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.
    Yazji I; Sodhi CP; Lee EK; Good M; Egan CE; Afrazi A; Neal MD; Jia H; Lin J; Ma C; Branca MF; Prindle T; Richardson WM; Ozolek J; Billiar TR; Binion DG; Gladwin MT; Hackam DJ
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9451-6. PubMed ID: 23650378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.
    Good M; Sodhi CP; Egan CE; Afrazi A; Jia H; Yamaguchi Y; Lu P; Branca MF; Ma C; Prindle T; Mielo S; Pompa A; Hodzic Z; Ozolek JA; Hackam DJ
    Mucosal Immunol; 2015 Sep; 8(5):1166-79. PubMed ID: 25899687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
    Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
    Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine downregulates TLR-2 and TLR-4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis.
    Zhou W; Li W; Zheng XH; Rong X; Huang LG
    J Pediatr Surg; 2014 Jul; 49(7):1057-63. PubMed ID: 24952788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.